KensaGroup creates, launches and develops leading edge intellectual property platforms into successful technology-based businesses. KensaGroup uses a proprietary approach to identify and evaluate promising discoveries from universities and corporate research initiatives, then creates the necessary scientific, institutional, and financial bridges that lead from initial discovery to successful commercialization.
09.06.18 - Collaboration to apply causal artificial intelligence and clinical trial data to identify factors that drive treatment response in patients with metastatic colorectal cancer...more
08.16.18 - Via CEO presents at 2018 Energy Impact Partners Roundtable and Iberdrola's Innoday...more
06.11.18 - 2018 R&D teams of the year: Grainful...more
05.10.18 - Mayo Clinic researchers study sterilization methods and materials related to vascular heart disease (VHD) treatment...more
04.23.18 - Grainful is redefining the most important meal of the day ...more
03.29.18 - GNS Healthcare using AI and longitudinal data to better multiple myeloma...more
KensaGroup, LLC
2415 N. Triphammer Road
Ithaca, NY 14850
phone: 1.607.330.2307
Fax: 1.607.330.2319